Patient advocacy group collaboration in genetic research and the scope of joint inventorship under US patent law
by Jordan Paradise
International Journal of Intellectual Property Management (IJIPM), Vol. 3, No. 2, 2009

Abstract: Patent systems have traditionally operated to reward scientific innovation and discovery rather than the level and type of contribution of raw materials and other support. In recently naming a non-scientist patent advocate as a co-inventor on a patent claiming method for diagnosing a disease-causing genetic mutation, the USPTO has recently determined that collaboration with researchers in providing banked genetic samples and participating in the laboratory rises to the level of inventorship. This article examines broad questions of ownership in genetic material, patient advocacy efforts in collaborative research and the traditional distinction in the patent realm between ownership and inventorship.

Online publication date: Sun, 15-Feb-2009

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com